Ashwani Marwah

A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19

Suresh Kumar, Rosemarie de Souza, Milind Nadkar et al. · Expert Opinion on Biological Therapy · 2021 · 33 citations · Full text

Media milling process optimization for manufacture of drug nanoparticles using design of experiments (DOE)

Vijaykumar Nekkanti, Ashwani Marwah, Raviraj Pillai · Drug Development and Industrial Pharmacy · 2013 · 30 citations

Nanoparticles, Engineering, Mechanical Engineering +17

Efficacy and safety of Tregopil, a novel, ultra-rapid acting oral prandial insulin analog, as part of a basal-bolus regimen in type 2 diabetes: a randomized, active-controlled phase 2/3 study

Harold E. Lebovitz, Alexander Fleming, Alan D. Cherrington et al. · Expert Opinion on Pharmacotherapy · 2022 · 15 citations

Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer

Hope S. Rugo, Eduardo J. Pennella, Unmesh Gopalakrishnan et al. · Breast Cancer Research and Treatment · 2021 · 12 citations · Full text